Surgirus Filleted Accounts Cover |  |

| Surgirus |
|  | Company No. 07785475 |  |
|  |  | Information for Filing with The Registrar |  |  |
|  |  | 31 March 2025 |  |  |

Surgirus Directors Report Registrar |  |

The Directors present their report and the accounts for the year ended 31 March 2025.
Principal activities |  |  |  |  |
The principal activity of the company during the year under review was Provision of medical services.
Bounce Back Loan
The Directors have repaid the Bounce back loan during the year.
Directors |  |  |  |  |
The Directors who served at any time during the year were as follows:
S. Seetharam |  |  |  |  |  |  |
M. Sudhanva |  |  |  |  |  |  |
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board |  |  |  |
M. Sudhanva |  |  |  |  |  |
Director |  |  |  |  |  |
24 December 2025 |  |  |  |  |  |

Surgirus Balance Sheet Registrar |  |

at | 31 March 2025 |  |  |  |  |  |  |
Company No. | 07785475 |  | Notes | 2025 |  |  |  | 2024
|  |  |  |  |  | £ |  |  |  | £
Fixed assets |  |  |  |  |  |  |
| Tangible assets |  | 5 | - |  |  |  | -
| Investments |  | 6 | 179,295 |  |  |  | 179,295
|  |  |  |  |  | 179,295 |  |  |  | 179,295
Current assets |  |  |  |  |  |  |
| Debtors |  | 7 | 43,790 |  |  |  | 1,050
| Cash at bank and in hand |  |  | 404,500 |  |  |  | 258,852
|  |  |  |  |  | 448,290 |  |  |  | 259,902
Creditors: Amount falling due within one year | 8 | (53,514) |  |  |  | (28,489)
Net current assets |  |  | 394,776 |  |  |  | 231,413
Total assets less current liabilities |  |  | 574,071 |  |  |  | 410,708
Net assets |  |  | 574,071 |  |  |  | 410,708
Capital and reserves |  |  |  |  |  |  |
| Called up share capital |  |  | 100 |  |  |  | 100
| Profit and loss account |  | 10 | 573,971 |  |  |  | 410,608
Total equity |  |  | 574,071 |  |  |  | 410,708
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 24 December 2025 and signed on its behalf by: |  |
M. Sudhanva |  |  |  |  |  |  |
Director |  |  |  |  |  |  |
24 December 2025 |  |  |  |  |  |  |  |

Surgirus Notes to the Accounts Registrar |  |

for the year ended 31 March 2025 |  |  |  |  |  |  |  |

1 | General information |  |
| Surgirus is a private company limited by shares and incorporated in England and Wales.
| Its registered number is: 07785475 |  |  |  |  |  |
| Its registered office is: |  |  |  |  |  |  |  |  |  |
| 44 Downs Hill |  |  |  |  |  |  |  |  |  |
| Beckenham |  |  |  |  |  |  |  |  |  |
| Kent |  |  |  |  |  |  |  |  |  |
| BR3 5HB |  |  |  |  |  |
| The accounts have been prepared in accordance and comply with FRS 102 and Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

2 | Accounting policies |  |  |  |  |  |  |  |

| Intangible fixed assets |  |  |  |  |  |  |  |
| Intangible fixed assets are carried at cost less accumulated amortisation and impairment losses.

| Research and development costs |  |  |  |  |  |  |
| Expenditure on research and development is written off in the year it is incurred unless it meets the criteria to allow it to be capitalised. Costs of research are always written off in the year in which they are incurred. Where development costs are recognised as an asset, they are amortised over the period expected to benefit from them. Amortisation of the capitalised costs begins once the developed product comes into use, typically at rate of 33.33% straight line.

| Taxation |  |  |  |  |  |
| Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable temporary differences. Deferred tax assets are generally recognised for all deductible timing differences to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Current or deferred tax for the year is recognised in profit or loss, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.

| Freehold investment property |  |  |  |  |  |  |  |
| Investment properties are revalued annually and any surplus or deficit is dealt with through the profit and loss account. No depreciation is provided in respect of investment properties.

| Investments |  |  |  |  |  |  |  |
| Unlisted investments (except those held as subsidiaries, associates or joint ventures) are recognised initially at fair value less attributable transaction costs. Subsequent to initial recognition, any changes in fair value are recognised in profit and loss.

| Stocks |  |  |  |  |  |  |  |
| Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs. When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of inventories recognised as an expense in the period in which the reversal occurs. Work in progress is reflected in the accounts on a contract by contract basis by recording revenue and related costs as contract activity progresses.

| Trade and other debtors |  |  |  |  |  |  |  |
| Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.

| Trade and other creditors |  |  |  |  |  |  |  |
| Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

| Foreign currencies |  |  |  |  |  |  |  |
| The functional and presentational currency of the company is Sterling. The accounts are rounded to the nearest pound.
| Transactions in currencies, other than the functional currency of the Company, are recorded at the rate of exchange on the date the transaction occurred. Monetary items denominated in other currencies are translated at the rate prevailing at the end of the reporting period. all differences are taken to the profit and loss account. Non-monetary items that are measured at historic cost in a foreign currency are not retranslated.

| Provisions |  |  |  |  |  |  |  |
| Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation. Provisions are charged as an expense to the profit and loss account in the year that the Company becomes aware of the obligation, and are measured at the best estimate at balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties. When payments are eventually made, they are charged to the provision carried in the balance sheet.

3 | Employees |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | Number |  |  |  | Number
|  | The average monthly number of employees (including directors) during the year was: | 2 |  |  |  | 2

4 | Taxation |  |  |  |  |  |  |  |
|  | (a) Tax on profit on ordinary activities |  |  | 2025 |  |  |  | 2024
|  | The tax charge is made up as follows: |  |  |  | £ |  |  |  | £
|  | UK corporation tax |  |  |  |  |  |  |  |
|  | Charge for the period |  |  |  | 50,341 |  |  |  | 23,988
|  | Total corporation tax |  |  |  | 50,341 |  |  |  | 23,988
|  | Tax on profit on ordinary activities |  |  |  | 50,341 |  |  |  | 23,988
|  | (b) Factors affecting the total tax charge for the period |  |  |  |  |
|  | The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The differences are reconciled below:
|  | Higher |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  | 50341 |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Profit on ordinary activities before tax |  |  |  | 216,203 |  |  |  | 117,649
|  | Profit on ordinary activities multiplied by standard rate of corporation tax in the United Kingdom |  | - |  |  |  | -
|  | Expenses not deductible for tax purposes |  | 50,341 |  |  |  | 23,988
|  | Tax on profit on ordinary activities |  |  |  | 50,341 |  |  |  | 23,988

5 | Tangible fixed assets |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |  |  | Motor vehicles |  | Total
|  |  |  |  |  |  |  |  |  |  |  | £ |  | £
|  | Cost or revaluation |  |  |  |  |  |  |  |  |  |
|  | At 1 April 2024 |  |  |  |  |  |  |  | 33,295 |  | 33,295
|  | At 31 March 2025 |  |  |  |  |  |  |  | 33,295 |  | 33,295
|  | Depreciation |  |  |  |  |  |  |  |  |  |
|  | At 1 April 2024 |  |  |  |  |  |  |  | 33,295 |  | 33,295
|  | At 31 March 2025 |  |  |  |  |  |  |  | 33,295 |  | 33,295
|  | Net book values |  |  |  |  |  |  |  |  |  |
|  | At 31 March 2025 |  |  |  |  |  |  |  | - |  | -
|  | At 31 March 2024 |  |  |  |  |  |  |  | - |  | -

6 | Investments |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |  |  | Other investments |  | Total
|  |  |  |  |  |  |  |  |  |  |  | £ |  | £
|  | Cost or valuation |  |  |  |  |  |  |  |  |  |
|  | At 1 April 2024 |  |  |  |  |  |  |  | 179,295 |  | 179,295
|  | At 31 March 2025 |  |  |  |  |  |  |  | 179,295 |  | 179,295
|  | Provisions/Impairment |  |  |  |  |  |  |  |  |  |
|  | Net book values |  |  |  |  |  |  |  |  |  |
|  | At 31 March 2025 |  |  |  |  |  |  |  | 179,295 |  | 179,295
|  | At 31 March 2024 |  |  |  |  |  |  |  | 179,295 |  | 179,295

7 | Debtors |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Loans to directors |  |  |  | 42,740 |  |  |  | -
|  | Other debtors |  |  |  | 1,050 |  |  |  | 1,050
|  |  |  |  |  |  |  |  |  | 43,790 |  |  |  | 1,050

8 | Creditors: |  |  |  |  |  |  |  |
|  | amounts falling due within one year |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Taxes and social security |  |  |  | 51,513 |  |  |  | 24,077
|  | Loans from directors |  |  |  | 2,000 |  |  |  | 3,502
|  | Other creditors |  |  |  | - |  |  |  | 909
|  | Accruals and deferred income |  |  |  | 1 |  |  |  | 1
|  |  |  |  |  |  |  |  |  | 53,514 |  |  |  | 28,489

9 | Share Capital |  |  |  |  |  |  |  |
|  | Ordinary

10 | Reserves |  |  |  |  |  |  |  |
|  | Profit and loss account - includes all current and prior period retained profits and losses.

11 | Dividends |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Dividends for the period: |  |  |  |  |  |  |  |
|  | Dividends paid in the period |  |  |  | 2,500 |  |  |  | 6,000
|  |  |  |  |  |  |  |  |  | 2,500 |  |  |  | 6,000
|  | Dividends by type: |  |  |  |  |  |  |  |
|  | Equity dividends |  |  |  | 2,500 |  |  |  | 6,000
|  |  |  |  |  |  |  |  |  | 2,500 |  |  |  | 6,000

Surgirus 07785475 31 March 2025 01 April 2024 false 24 December 2025 BTCSoftware AP Solution 2025 12.2.02 12.2.02 true 07785475 2024-04-01 2025-03-31 07785475 2025-03-31 07785475 2024-03-31 07785475 core:WithinOneYear 2025-03-31 07785475 core:WithinOneYear 2024-03-31 07785475 core:ShareCapital 2025-03-31 07785475 core:ShareCapital 2024-03-31 07785475 core:RetainedEarningsAccumulatedLosses 2025-03-31 07785475 core:RetainedEarningsAccumulatedLosses 2024-03-31 07785475 countries:UnitedKingdom 2024-04-01 2025-03-31 07785475 bus:RegisteredOffice 2024-04-01 2025-03-31 07785475 2023-04-01 2024-03-31 07785475 core:MotorVehicles 2024-04-01 07785475 2024-04-01 07785475 core:MotorVehicles 2025-03-31 07785475 core:CostValuation 2024-04-01 07785475 core:CostValuation 2025-03-31 07785475 core:CostValuation core:UnlistedNon-exchangeTraded 2025-03-31 07785475 core:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 07785475 bus:AllOrdinaryShares 2024-04-01 2025-03-31 07785475 bus:SmallEntities 2024-04-01 2025-03-31 07785475 bus:FullAccounts 2024-04-01 2025-03-31 07785475 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 07785475 bus:Director2 2024-04-01 2025-03-31 07785475 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure